2.4.0.8 Html 205 348 1 true 70 0 false 13 false false R1.htm 001 - Document - Document and Entity Information Sheet http://www.delmarpharma.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 002 - Statement - Consolidated Balance Sheets Sheet http://www.delmarpharma.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets false false R3.htm 003 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.delmarpharma.com/role/ConsolidatedBalanceSheetsParentheticals Consolidated Balance Sheets (Parentheticals) false false R4.htm 004 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.delmarpharma.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveLoss Consolidated Statements of Operations and Comprehensive Loss false false R5.htm 005 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Deficiency) Sheet http://www.delmarpharma.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficiency Consolidated Statements of Changes in Stockholders' Equity (Deficiency) false false R6.htm 006 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Deficiency) (Parentheticals) Sheet http://www.delmarpharma.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficiencyParentheticals Consolidated Statements of Changes in Stockholders' Equity (Deficiency) (Parentheticals) false false R7.htm 007 - Statement - Consolidated Statements of Cash Flows Sheet http://www.delmarpharma.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows false false R8.htm 008 - Statement - Consolidated Statements of Cash Flows (Parentheticals) Sheet http://www.delmarpharma.com/role/ConsolidatedStatementsOfCashFlowsParentheticals Consolidated Statements of Cash Flows (Parentheticals) false false R9.htm 009 - Disclosure - Nature of operations and going concern Sheet http://www.delmarpharma.com/role/NatureOfOperationsAndGoingConcern Nature of operations and going concern false false R10.htm 010 - Disclosure - Significant accounting policies Sheet http://www.delmarpharma.com/role/SignificantAccountingPolicies Significant accounting policies false false R11.htm 011 - Disclosure - Reverse acquisition Sheet http://www.delmarpharma.com/role/ReverseAcquisition Reverse acquisition false false R12.htm 012 - Disclosure - Valent Technologies LLC agreement Sheet http://www.delmarpharma.com/role/ValentTechnologiesLlcAgreement Valent Technologies LLC agreement false false R13.htm 013 - Disclosure - Taxes and other receivables Sheet http://www.delmarpharma.com/role/TaxesAndOtherReceivables Taxes and other receivables false false R14.htm 014 - Disclosure - Accounts payable and accrued liabilities Sheet http://www.delmarpharma.com/role/AccountsPayableAndAccruedLiabilities Accounts payable and accrued liabilities false false R15.htm 015 - Disclosure - Derivative liability Sheet http://www.delmarpharma.com/role/DerivativeLiability Derivative liability false false R16.htm 016 - Disclosure - Stockholders' deficiency Sheet http://www.delmarpharma.com/role/StockholdersDeficiency Stockholders' deficiency false false R17.htm 017 - Disclosure - Related party transactions Sheet http://www.delmarpharma.com/role/RelatedPartyTransactions Related party transactions false false R18.htm 018 - Disclosure - Current and future income taxes Sheet http://www.delmarpharma.com/role/CurrentAndFutureIncomeTaxes Current and future income taxes false false R19.htm 019 - Disclosure - Commitments and contingencies Sheet http://www.delmarpharma.com/role/CommitmentsAndContingencies Commitments and contingencies false false R20.htm 020 - Disclosure - Financial risk management Sheet http://www.delmarpharma.com/role/FinancialRiskManagement Financial risk management false false R21.htm 021 - Disclosure - Subsequent events Sheet http://www.delmarpharma.com/role/SubsequentEvents Subsequent events false false R22.htm 022 - Disclosure - Significant accounting policies (Policies) Sheet http://www.delmarpharma.com/role/SignificantAccountingPoliciesPolicies Significant accounting policies (Policies) false false R23.htm 023 - Disclosure - Significant accounting policies (Tables) Sheet http://www.delmarpharma.com/role/SignificantAccountingPoliciesTables Significant accounting policies (Tables) false false R24.htm 024 - Disclosure - Reverse acquisition (Tables) Sheet http://www.delmarpharma.com/role/ReverseacquisitionTables Reverse acquisition (Tables) false false R25.htm 025 - Disclosure - Taxes and other receivables (Tables) Sheet http://www.delmarpharma.com/role/TaxesAndOtherReceivablesTables Taxes and other receivables (Tables) false false R26.htm 026 - Disclosure - Accounts payable and accrued liabilities(Tables) Sheet http://www.delmarpharma.com/role/AccountsPayableAndAccruedLiabilitiestables Accounts payable and accrued liabilities(Tables) false false R27.htm 027 - Disclosure - Derivative liability (Tables) Sheet http://www.delmarpharma.com/role/DerivativeliabilityTables Derivative liability (Tables) false false R28.htm 028 - Disclosure - Stockholders' deficiency (Tables) Sheet http://www.delmarpharma.com/role/StockholdersDeficiencyTables Stockholders' deficiency (Tables) false false R29.htm 029 - Disclosure - Current and future income taxes (Tables) Sheet http://www.delmarpharma.com/role/Currentandfutureincometaxestables Current and future income taxes (Tables) false false R30.htm 030 - Disclosure - Financial risk management (Tables) Sheet http://www.delmarpharma.com/role/FinancialRiskManagementTables Financial risk management (Tables) false false R31.htm 031 - Disclosure - Nature of operations and going concern (Detail Textuals) Sheet http://www.delmarpharma.com/role/NatureOfOperationsAndGoingConcernDetailTextuals Nature of operations and going concern (Detail Textuals) false false R32.htm 032 - Disclosure - Significant accounting policies (Details) Sheet http://www.delmarpharma.com/role/Significantaccountingpoliciesdetails Significant accounting policies (Details) false false R33.htm 033 - Disclosure - Significant accounting policies (Detail Textuals) Sheet http://www.delmarpharma.com/role/Significantaccountingpoliciesdetailtextuals Significant accounting policies (Detail Textuals) false false R34.htm 034 - Disclosure - Reverse acquisition - Net identifiable liabilities (Details) Sheet http://www.delmarpharma.com/role/ReverseAcquisitionNetIdentifiableLiabilitiesDetails Reverse acquisition - Net identifiable liabilities (Details) false false R35.htm 035 - Disclosure - Reverse acquisition (Detail Textuals) Sheet http://www.delmarpharma.com/role/ReverseAcquisitionDetailTextuals Reverse acquisition (Detail Textuals) false false R36.htm 036 - Disclosure - Valent Technologies LLC agreement (Detail Textuals) Sheet http://www.delmarpharma.com/role/ValentTechnologiesLLCAgreementDetailTextuals Valent Technologies LLC agreement (Detail Textuals) false false R37.htm 037 - Disclosure - Taxes and other receivables (Details) Sheet http://www.delmarpharma.com/role/TaxesAndOtherReceivablesDetails Taxes and other receivables (Details) false false R38.htm 038 - Disclosure - Taxes and other receivables (Details Textuals) Sheet http://www.delmarpharma.com/role/TaxesAndOtherReceivablesDetailsTextuals Taxes and other receivables (Details Textuals) false false R39.htm 039 - Disclosure - Accounts payable and accrued liabilities (Details) Sheet http://www.delmarpharma.com/role/AccountsPayableAndAccruedLiabilitiesDetails Accounts payable and accrued liabilities (Details) false false R40.htm 040 - Disclosure - Accounts payable and accrued liabilities (Details Textual) Sheet http://www.delmarpharma.com/role/AccountsPayableAndAccruedLiabilitiesDetailsTextual Accounts payable and accrued liabilities (Details Textual) false false R41.htm 041 - Disclosure - Derivative liability - Summary of derivative liability (Details) Sheet http://www.delmarpharma.com/role/DerivativeLiabilitySummaryOfDerivativeLiabilityDetails Derivative liability - Summary of derivative liability (Details) false false R42.htm 042 - Disclosure - Derivative liability (Detail Textuals) Sheet http://www.delmarpharma.com/role/DerivativeLiabilityDetailTextuals Derivative liability (Detail Textuals) false false R43.htm 043 - Disclosure - Derivative liability (Detail Textuals 1) Sheet http://www.delmarpharma.com/role/DerivativeLiabilityDetailTextuals1 Derivative liability (Detail Textuals 1) false false R44.htm 044 - Disclosure - Derivative liability (Detail Textuals 2) Sheet http://www.delmarpharma.com/role/DerivativeLiabilityDetailTextuals2 Derivative liability (Detail Textuals 2) false false R45.htm 045 - Disclosure - Stockholders' deficiency - Number of shares held in trust (Details) Sheet http://www.delmarpharma.com/role/StockholdersDeficiencyNumberOfSharesHeldInTrustDetails Stockholders' deficiency - Number of shares held in trust (Details) false false R46.htm 046 - Disclosure - Stockholders' deficiency - Options outstanding under Plan (Details 1) Sheet http://www.delmarpharma.com/role/StockholdersDeficiencyOptionsOutstandingUnderPlanDetails1 Stockholders' deficiency - Options outstanding under Plan (Details 1) false false R47.htm 047 - Disclosure - Stockholders' deficiency - Stock options outstanding and exercisable (Details 2) Sheet http://www.delmarpharma.com/role/Stockholdersdeficiencystockoptionsoutstandingandexercisabledetails2 Stockholders' deficiency - Stock options outstanding and exercisable (Details 2) false false R48.htm 048 - Disclosure - Stockholders' deficiency - Stock options valuation assumptions (Details 3) Sheet http://www.delmarpharma.com/role/StockholdersDeficiencyStockOptionsValuationAssumptionsDetails3 Stockholders' deficiency - Stock options valuation assumptions (Details 3) false false R49.htm 049 - Disclosure - Stockholders' deficiency - Stock-based compensation expense (Details 4) Sheet http://www.delmarpharma.com/role/StockholdersDeficiencyStockBasedCompensationExpenseDetails4 Stockholders' deficiency - Stock-based compensation expense (Details 4) false false R50.htm 050 - Disclosure - Stockholders' deficiency - Unvested stock options (Details 5) Sheet http://www.delmarpharma.com/role/StockholdersDeficiencyUnvestedStockOptionsDetails5 Stockholders' deficiency - Unvested stock options (Details 5) false false R51.htm 051 - Disclosure - Stockholders' deficiency - Warrants (Details 6) Sheet http://www.delmarpharma.com/role/StockholdersDeficiencyWarrantsDetails6 Stockholders' deficiency - Warrants (Details 6) false false R52.htm 052 - Disclosure - Stockholders' deficiency - Summary of outstanding warrants (Details 7) Sheet http://www.delmarpharma.com/role/Stockholdersdeficiencysummaryofoutstandingwarrantsdetails7 Stockholders' deficiency - Summary of outstanding warrants (Details 7) false false R53.htm 053 - Disclosure - Stockholders' deficiency (Detail Textuals) Sheet http://www.delmarpharma.com/role/StockholdersDeficiencyDetailTextuals Stockholders' deficiency (Detail Textuals) false false R54.htm 054 - Disclosure - Stockholders' deficiency (Detail Textuals 1) Sheet http://www.delmarpharma.com/role/StockholdersDeficiencyDetailTextuals1 Stockholders' deficiency (Detail Textuals 1) false false R55.htm 055 - Disclosure - Stockholders' deficiency (Detail Textuals 2) Sheet http://www.delmarpharma.com/role/StockholdersDeficiencyDetailTextuals2 Stockholders' deficiency (Detail Textuals 2) false false R56.htm 056 - Disclosure - Stockholders' deficiency (Detail Textuals 3) Sheet http://www.delmarpharma.com/role/StockholdersDeficiencyDetailTextuals3 Stockholders' deficiency (Detail Textuals 3) false false R57.htm 057 - Disclosure - Stockholders' deficiency (Detail Textuals 4) Sheet http://www.delmarpharma.com/role/StockholdersDeficiencyDetailTextuals4 Stockholders' deficiency (Detail Textuals 4) false false R58.htm 058 - Disclosure - Stockholders' deficiency (Detail Textuals 5) Sheet http://www.delmarpharma.com/role/StockholdersDeficiencyDetailTextuals5 Stockholders' deficiency (Detail Textuals 5) false false R59.htm 059 - Disclosure - Stockholders' deficiency (Detail Textuals 6) Sheet http://www.delmarpharma.com/role/StockholdersDeficiencyDetailTextuals6 Stockholders' deficiency (Detail Textuals 6) false false R60.htm 060 - Disclosure - Stockholders' deficiency (Details Textuals 7) Sheet http://www.delmarpharma.com/role/StockholdersDeficiencyDetailsTextuals7 Stockholders' deficiency (Details Textuals 7) false false R61.htm 061 - Disclosure - Stockholders' deficiency (Details Textual 8) Sheet http://www.delmarpharma.com/role/StockholdersDeficiencyDetailsTextual8 Stockholders' deficiency (Details Textual 8) false false R62.htm 062 - Disclosure - Related party transactions (Detail Textuals ) Sheet http://www.delmarpharma.com/role/RelatedPartyTransactionsDetailTextuals Related party transactions (Detail Textuals ) false false R63.htm 063 - Disclosure - Related party transactions (Detail Textuals 1) Sheet http://www.delmarpharma.com/role/RelatedPartyTransactionsDetailTextuals1 Related party transactions (Detail Textuals 1) false false R64.htm 064 - Disclosure - Related party transactions (Detail Textuals 2) Sheet http://www.delmarpharma.com/role/Relatedpartytransactionsdetailtextuals2 Related party transactions (Detail Textuals 2) false false R65.htm 065 - Disclosure - Current and future income taxes - Taxable income (Details) Sheet http://www.delmarpharma.com/role/CurrentAndFutureIncomeTaxesTaxableIncomeDetails Current and future income taxes - Taxable income (Details) false false R66.htm 066 - Disclosure - Current and future income taxes - future tax assets (Details 1) Sheet http://www.delmarpharma.com/role/CurrentAndFutureIncomeTaxesFutureTaxAssetsDetails1 Current and future income taxes - future tax assets (Details 1) false false R67.htm 067 - Disclosure - Current and future income taxes - Effective income tax differ statutory income tax (Details 2) Sheet http://www.delmarpharma.com/role/CurrentAndFutureIncomeTaxesEffectiveIncomeTaxDifferStatutoryIncomeTaxDetails2 Current and future income taxes - Effective income tax differ statutory income tax (Details 2) false false R68.htm 068 - Disclosure - Current and future income taxes (Details Textual) Sheet http://www.delmarpharma.com/role/CurrentAndFutureIncomeTaxesDetailsTextual Current and future income taxes (Details Textual) false false R69.htm 069 - Disclosure - Commitments and contingencies (Details Textual) Sheet http://www.delmarpharma.com/role/CommitmentsAndContingenciesDetailsTextual Commitments and contingencies (Details Textual) false false R70.htm 070 - Disclosure - Financial risk management (Details) Sheet http://www.delmarpharma.com/role/FinancialRiskManagementDetails Financial risk management (Details) false false R71.htm 071 - Disclosure - Financial risk management (Details 1) Sheet http://www.delmarpharma.com/role/FinancialRiskManagementDetails1 Financial risk management (Details 1) false false R72.htm 072 - Disclosure - Financial risk management (Detail Textuals) Sheet http://www.delmarpharma.com/role/FinancialRiskManagementDetailTextuals Financial risk management (Detail Textuals) false false R73.htm 073 - Disclosure - Subsequent events (Detail Textuals) Sheet http://www.delmarpharma.com/role/SubsequentEventsDetailTextuals Subsequent events (Detail Textuals) false false All Reports Book All Reports Element us-gaap_EquityIssuancePerShareAmount had a mix of decimals attribute values: 2 3. Element us-gaap_FairValueAssumptionsExpectedVolatilityRate had a mix of decimals attribute values: 2 4. Element us-gaap_FairValueAssumptionsRiskFreeInterestRate had a mix of decimals attribute values: 3 4. 'Monetary' elements on report '033 - Disclosure - Significant accounting policies (Detail Textuals)' had a mix of different decimal attribute values. Process Flow-Through: 002 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: Removing column 'Apr. 06, 2010' Process Flow-Through: 003 - Statement - Consolidated Balance Sheets (Parentheticals) Process Flow-Through: 004 - Statement - Consolidated Statements of Operations and Comprehensive Loss Process Flow-Through: Removing column '9 Months Ended Dec. 31, 2010' Process Flow-Through: 006 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Deficiency) (Parentheticals) Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2013 CDN' Process Flow-Through: 007 - Statement - Consolidated Statements of Cash Flows Process Flow-Through: 008 - Statement - Consolidated Statements of Cash Flows (Parentheticals) dmpi-20131231.xml dmpi-20131231.xsd dmpi-20131231_cal.xml dmpi-20131231_def.xml dmpi-20131231_lab.xml dmpi-20131231_pre.xml true true